143 related articles for article (PubMed ID: 22419031)
1. Narciclasine as well as other Amaryllidaceae isocarbostyrils are promising GTP-ase targeting agents against brain cancers.
Van Goietsenoven G; Mathieu V; Lefranc F; Kornienko A; Evidente A; Kiss R
Med Res Rev; 2013 Mar; 33(2):439-55. PubMed ID: 22419031
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents.
Ingrassia L; Lefranc F; Dewelle J; Pottier L; Mathieu V; Spiegl-Kreinecker S; Sauvage S; El Yazidi M; Dehoux M; Berger W; Van Quaquebeke E; Kiss R
J Med Chem; 2009 Feb; 52(4):1100-14. PubMed ID: 19199649
[TBL] [Abstract][Full Text] [Related]
3. Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas.
Van Goietsenoven G; Hutton J; Becker JP; Lallemand B; Robert F; Lefranc F; Pirker C; Vandenbussche G; Van Antwerpen P; Evidente A; Berger W; Prévost M; Pelletier J; Kiss R; Kinzy TG; Kornienko A; Mathieu V
FASEB J; 2010 Nov; 24(11):4575-84. PubMed ID: 20643906
[TBL] [Abstract][Full Text] [Related]
4. Narciclasine - an Amaryllidaceae Alkaloid with Potent Antitumor and Anti-Inflammatory Properties.
Fürst R
Planta Med; 2016 Nov; 82(16):1389-1394. PubMed ID: 27542176
[TBL] [Abstract][Full Text] [Related]
5. Narciclasine, a plant growth modulator, activates Rho and stress fibers in glioblastoma cells.
Lefranc F; Sauvage S; Van Goietsenoven G; Mégalizzi V; Lamoral-Theys D; Debeir O; Spiegl-Kreinecker S; Berger W; Mathieu V; Decaestecker C; Kiss R
Mol Cancer Ther; 2009 Jul; 8(7):1739-50. PubMed ID: 19531573
[TBL] [Abstract][Full Text] [Related]
6. Narciclasine, an isocarbostyril alkaloid, has preferential activity against primary effusion lymphoma.
Gopalakrishnan R; Matta H; Choi S; Chaudhary PM
Sci Rep; 2020 Mar; 10(1):5712. PubMed ID: 32235878
[TBL] [Abstract][Full Text] [Related]
7. Narciclasine-4-
Katoch D; Kumar D; Padwad YS; Singh B; Sharma U
Nat Prod Res; 2020 Jan; 34(2):233-240. PubMed ID: 30636443
[TBL] [Abstract][Full Text] [Related]
8. Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells.
Van Goietsenoven G; Andolfi A; Lallemand B; Cimmino A; Lamoral-Theys D; Gras T; Abou-Donia A; Dubois J; Lefranc F; Mathieu V; Kornienko A; Kiss R; Evidente A
J Nat Prod; 2010 Jul; 73(7):1223-7. PubMed ID: 20550100
[TBL] [Abstract][Full Text] [Related]
9. Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.
Lamoral-Theys D; Andolfi A; Van Goietsenoven G; Cimmino A; Le Calvé B; Wauthoz N; Mégalizzi V; Gras T; Bruyère C; Dubois J; Mathieu V; Kornienko A; Kiss R; Evidente A
J Med Chem; 2009 Oct; 52(20):6244-56. PubMed ID: 19788245
[TBL] [Abstract][Full Text] [Related]
10. Biological evaluation of ent-narciclasine, ent-lycoricidine, and certain enantiomerically-related congeners.
Matveenko M; Banwell MG; Joffe M; Wan S; Fantino E
Chem Biodivers; 2009 May; 6(5):685-91. PubMed ID: 19479847
[TBL] [Abstract][Full Text] [Related]
11. Narciclasine improves outcome in sepsis among neonatal rats via inhibition of calprotectin and alleviating inflammatory responses.
Kingsley MK; Bhat BV; Badhe BA; Dhas BB; Parija SC
Sci Rep; 2020 Feb; 10(1):2947. PubMed ID: 32076015
[TBL] [Abstract][Full Text] [Related]
12. Narciclasine attenuates sepsis-induced myocardial injury by modulating autophagy.
Tang R; Jia L; Li Y; Zheng J; Qi P
Aging (Albany NY); 2021 May; 13(11):15151-15163. PubMed ID: 34035183
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis-inducing effects of distichamine and narciprimine, rare alkaloids of the plant family Amaryllidaceae.
Nair JJ; Rárová L; Strnad M; Bastida J; van Staden J
Bioorg Med Chem Lett; 2012 Oct; 22(19):6195-9. PubMed ID: 22921081
[TBL] [Abstract][Full Text] [Related]
14. Amaryllidaceae Alkaloids Decrease the Proliferation, Invasion, and Secretion of Clinically Relevant Cytokines by Cultured Human Colon Cancer Cells.
Mathieu V; Laguera B; Masi M; Dulanto SA; Bingham TW; Hernandez LW; Sarlah D; Evidente A; Lafontaine DLJ; Kornienko A; Lane MA
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139106
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic agents of the crinane series of amaryllidaceae alkaloids.
Nair JJ; Bastida J; Viladomat F; van Staden J
Nat Prod Commun; 2012 Dec; 7(12):1677-88. PubMed ID: 23413581
[TBL] [Abstract][Full Text] [Related]
16. Narciclasine induces autophagy-dependent apoptosis in triple-negative breast cancer cells by regulating the AMPK-ULK1 axis.
Cao C; Huang W; Zhang N; Wu F; Xu T; Pan X; Peng C; Han B
Cell Prolif; 2018 Dec; 51(6):e12518. PubMed ID: 30152053
[TBL] [Abstract][Full Text] [Related]
17. Narciclasine suppresses esophageal cancer cell proliferation and migration by inhibiting the FAK signaling pathway.
Qiu Y; Fang B; Thuy NTT; Li A; Yoo HM; Zheng X; Cho N
Eur J Pharmacol; 2022 Apr; 921():174669. PubMed ID: 35248554
[TBL] [Abstract][Full Text] [Related]
18. Biological evaluation of structurally diverse amaryllidaceae alkaloids and their synthetic derivatives: discovery of novel leads for anticancer drug design.
Evidente A; Kireev AS; Jenkins AR; Romero AE; Steelant WF; Van Slambrouck S; Kornienko A
Planta Med; 2009 Apr; 75(5):501-7. PubMed ID: 19235683
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo behaviour of narciclasine released from matrices based on poly (2-hydroxyethyl methacrylate).
Veronese FM; Ceriotti G; Baccichetti F; Carlassare F; Moschini F; Caliceti P; Schiavon O; Carenza M; Lora S
Farmaco; 1991 Sep; 46(9):1061-70. PubMed ID: 1807291
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of unnatural derivatives of narciclasine: 7-aza-nornarciclasine and its N-oxide.
Vshyvenko S; Reisenauer MR; Rogelj S; Hudlicky T
Bioorg Med Chem Lett; 2014 Sep; 24(17):4236-8. PubMed ID: 25108300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
